Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TriCAR-T-CD19 in R/R NHL
NCT03497533Phase 2Unknown
- Sponsor
- Timmune Biotech
- Start
- Aug 2018
- Primary completion
- Dec 2020
- Modality
- Gene Editing, Gene Silencing, CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of CD19-TriCAR-T in non-Hodgkin lymphoma (NHL), sponsored by Timmune Biotech. Status: unknown.
02
Drugs
CD19-TriCAR-T
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT03497533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03497533.